State-of-the-art tools unveil potent drug targets amongst clinically approved drugs to inhibit helicase in SARS-CoV-2
oleh: J. Francis Borgio, Hind Saleh Alsuwat, Waad Mohammed Al Otaibi, Abdallah M. Ibrahim, Noor Almandil, Lubna Ibrahim Al Asoom, Mohammed Salahuddin, Balu Kamaraj, Sayed AbdulAzeez
| Format: | Article |
|---|---|
| Diterbitkan: | Termedia Publishing House 2020-04-01 |
Deskripsi
Subjek
covid-19; sars-cov-2; clinically approved drugs; molecular docking; helicase; antiretroviral agents